TRINITY BIOTECH PLC-SPON ADR (TRIB)

US8964385046 - ADR

1.98  -0.04 (-1.98%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

TRINITY BIOTECH PLC-SPON ADR

NASDAQ:TRIB (3/27/2024, 8:00:01 PM)

1.98

-0.04 (-1.98%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap75.65M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

TRIB Daily chart

Company Profile

Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. The company is headquartered in Bray, Wicklow and currently employs 398 full-time employees. The firm's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. Its segments include the Americas and Rest of World. The company is a provider of raw materials to the life sciences and research industries globally. The company also operates a licensed reference laboratory that specializes in diagnostics for autoimmune diseases. Its POC brands include Uni-Gold, Recombigen, MarDx, FlexTrans, Premier and Ultra. Its clinical laboratory brands include ImmuBlot, ImmuGlo, ImmuLisa, OTOblot, EZ and EZ. The company supplies this market with other products through its clinical chemistry business. The company manufactures kits for the detection of specialty and esoteric biomarkers of infectious diseases and other associated laboratory products.

Company Info

TRINITY BIOTECH PLC-SPON ADR

Ida Business Park, Bray, Co Wicklow, Ireland

BRAY WICKLOW

P: 35312769800

CEO: Ronan O'Caoimh

Employees: 398

Website: https://www.trinitybiotech.com/

TRIB News

News Image20 days ago - Trinity Biotech plcTrinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price Rule

DUBLIN, Ireland, March 08, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc. (NASDAQ: TRIB) (the “Company”) today reported the receipt of a formal...

News Imagea month ago - Trinity Biotech plcTrinity Biotech Plc Finalizes Effective Date of ADS Ratio Change

DUBLIN, Ireland, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc.(NASDAQ: TRIB) (the “Company”) today announced that it has finalized the effective...

News Imagea month ago - Seeking AlphaTrinity Biotech to implement ADS ratio change (NASDAQ:TRIB)

Trinity Biotech plans to change its ADS ratio, enabling compliance with Nasdaq's minimum bid price requirement and affecting ADS trading on February 21.

News Imagea month ago - Trinity Biotech plcTrinity Biotech Plc Announces Plan to Implement ADS Ratio Change

DUBLIN, Ireland, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc.(NASDAQ: TRIB) (the “Company”) today announced that it plans to change the ratio...

News Image2 months ago - Trinity Biotech plcTrinity Biotech to Present at Emerging Growth Conference

DUBLIN, Ireland, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), today announces that management will present...

News Image2 months ago - Trinity Biotech plcTrinity Biotech Announces Application for Early Sjogrens Syndrome Test Panel PLA Code

DUBLIN, Ireland, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc. (Nasdaq: TRIB) (the “Company”) today announced that its New York based reference...

TRIB Twits

Here you can normally see the latest stock twits on TRIB, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example